Last updated on November 2017

A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis


Brief description of study

A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis

Detailed Study Description

This is a study for a treatment to House Dust Mite Allergy.

Clinical Study Identifier: TX7260

Contact Investigators or Research Sites near you

Start Over

Clinical Research Atlanta

Stockbridge, GA USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.